Randomized controlled trial of osmotic-release methylphenidate with cognitive-behavioral therapy in adolescents with attention-deficit/hyperactivity disorder and substance use disorders - Wikidata - wikimedia - TriplyDB

Randomized controlled trial of osmotic-release methylphenidate with cognitive-behavioral therapy in adolescents with attention-deficit/hyperactivity disorder and substance use disorders

Randomized controlled trial of osmotic-release methylphenidate with cognitive-behavioral therapy in adolescents with attention-deficit/hyperactivity disorder and substance use disorders

http://www.wikidata.org/entity/Q35189691

about

Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)Are there any potentially dangerous pharmacological effects of combining ADHD medication with alcohol and drugs of abuse? A systematic review of the literature The complicated relationship between attention deficit/hyperactivity disorder and substance use disorders Neurobiology of adolescent substance use and addictive behaviors: treatment implications Treatment of Adolescent Substance Use Disorders and Co-Occurring Internalizing Disorders: A Critical Review and Proposed Model The importance of distribution-choice in modeling substance use data: a comparison of negative binomial, beta binomial, and zero-inflated distributions.Treatment of Adolescent Substance Use Disorders Towards Precision Addiction Treatment: New Findings in Co-morbid Substance Use and Attention-Deficit Hyperactivity Disorders.Pharmacological Treatment of ADHD in Addicted Patients: What Does the Literature Tell Us?Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study.The role of early childhood ADHD and subsequent CD in the initiation and escalation of adolescent cigarette, alcohol, and marijuana use.Evidence base on outpatient behavioral treatments for adolescent substance use: updates and recommendations 2007-2013.Prevalent intravenous abuse of methylphenidate among treatment-seeking patients with substance abuse disorders: a descriptive population-based study Clinical Strategies for Integrating Medication Interventions Into Behavioral Treatment for Adolescent ADHD: The Medication Integration Protocol Investigating the efficacy of integrated cognitive behavioral therapy for adult treatment seeking substance use disorder patients with comorbid ADHD: study protocol of a randomized controlled trial.Male adolescent substance use disorder and attention-deficit hyperactivity disorder: a review of the literature.Major depression and treatment response in adolescents with ADHD and substance use disorder.An application of analyzing the trajectories of two disorders: A parallel piecewise growth model of substance use and attention-deficit/hyperactivity disorder.Treatments for Adolescents With Comorbid ADHD and Substance Use Disorder: A Systematic Review.Substance-use disorders in adolescents and adults with ADHD: focus on treatment.Predictors of treatment response in adolescents with comorbid substance use disorder and attention-deficit/hyperactivity disorder.Gastrointestinal adverse events during methylphenidate treatment of children and adolescents with attention deficit hyperactivity disorder: A systematic review with meta-analysis and Trial Sequential Analysis of randomised clinical trials.Adolescent and caregiver reports of ADHD symptoms among inner-city youth: agreement, perceived need for treatment, and behavioral correlates Emerging Pharmacologic Treatments for Adolescent Substance Use: Challenges and New Directions.Pharmacotherapy for Substance Use Disorders in Youths.A review of OROS methylphenidate (Concerta(®)) in the treatment of attention-deficit/hyperactivity disorder.Pharmacological treatment of attention deficit hyperactivity disorder with co-morbid drug dependence.Attention deficit hyperactivity disorder and substance misuse: an evaluation of causal hypotheses and treatment considerations.Treating Mental Health and Substance Use Disorders in Adolescents: What Is on the Menu?Updates on treatment of attention-deficit/hyperactivity disorder: facts, comments, and ethical considerations.On estimating and testing associations between random coefficients from multivariate generalized linear mixed models of longitudinal outcomes.Pharmacotherapy for adolescent alcohol use disorder.Individualised short-term therapy for adolescents impaired by attention-deficit/hyperactivity disorder despite previous routine care treatment (ESCAadol)-Study protocol of a randomised controlled trial within the consortium ESCAlife.International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder.

P2860

Q22061981-986587E0-BB21-463A-A2F8-E74081F60FDB Q26777710-7C04191F-246D-47E5-B85B-DA9415384439 Q26851607-0B46B492-B9FC-418A-9297-08D6FD28F145 Q26852735-3E92153F-EA16-406A-9BD5-88F0AF997805 Q26866733-46942274-E543-4E92-B8CA-CA8BBD56787C Q30979242-0B193BF3-D294-4F3C-8977-74E767F9F396 Q33621337-267B6C69-33C2-48B2-BC8C-1E3C9DFB26A0 Q33919571-B29784EB-C14B-47B6-B6B9-E8479C2AECAC Q33919950-4D42ED7A-A61B-441B-9306-CEA0CBEA14B7 Q33957119-1EF33A0A-D237-4EF0-8B9E-17533644D6BC Q33994675-F07975D3-A4FD-4763-BC13-67B86161C017 Q34424651-48D5D90D-0FD6-4513-BCBF-D834F597D64C Q34466098-247AC753-B884-406D-8D3D-1318ADB879F4 Q34647061-8C8C4E6F-95FD-4061-BE95-D24EFCC3CDC2 Q34714758-98666BDB-846D-4F0C-AC89-DC17A2F6D725 Q35490379-0C788AAC-6FB4-41E3-8360-02FC08C52B98 Q35633131-77D4619E-AA84-4C60-B6E0-628672FC5886 Q36315683-F578EFCB-EB19-4A3C-B539-D218EFD88BCE Q36338808-C39D7331-F96E-4E32-953D-9C828FE7C6E2 Q36344412-5EFE307E-AA60-439F-9BEC-E1D5043EDB09 Q36403699-EB8A35E5-1748-43B1-916C-D0BCEBBF4168 Q36406224-1C78BC06-55F3-4394-8BDB-49F5BD56FDA6 Q36876248-56053111-EE0D-4EE9-B302-3FDC03233F47 Q37200944-D386F61A-6B9E-4ACA-AEA0-10B3478A39EE Q37574339-9CD904BB-A393-4103-8996-E461311680E4 Q38239633-C89440AC-9C62-48C2-B0AA-B633EF3D3077 Q38241724-CE4BE3BC-B7F5-4397-9C6C-E731F1B2B054 Q38569727-B799286C-A1C5-4869-93F1-EE73E223F863 Q38766157-AB3848EC-1546-4EA1-BAF2-B81D430AA29C Q41473870-E89BAE80-62A3-4139-9929-CA84BF8655D4 Q41504919-FC634B05-82C7-4B9A-B6C9-D0895AB68363 Q47984054-61B0E9C4-4DC2-425B-BB9B-ADC81A655103 Q54962458-7808791C-CE47-4500-BC34-7374238DC637 Q55339438-DD6B6CD2-C323-44CC-8093-420DA58809DA

P2860

Randomized controlled trial of osmotic-release methylphenidate with cognitive-behavioral therapy in adolescents with attention-deficit/hyperactivity disorder and substance use disorders

http://www.wikidata.org/entity/Q35189691

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Randomized controlled trial of ...... er and substance use disorders

@ast

Randomized controlled trial of ...... er and substance use disorders

@en

type

label

Randomized controlled trial of ...... er and substance use disorders

@ast

Randomized controlled trial of ...... er and substance use disorders

@en

prefLabel

Randomized controlled trial of ...... er and substance use disorders

@ast

Randomized controlled trial of ...... er and substance use disorders

@en

P1433

Q35189691-40AF4951-7684-4206-ABBE-1E82D805776C

P1476

Q35189691-6CBEC2F2-86A1-484D-B97B-05D4FE8CE054

P2093

Q35189691-10F0B169-78BA-489C-862F-21D36CBCD7B1

Q35189691-10FB3C26-566C-44AD-8ACF-BF90F08DBB26

Q35189691-14E2D369-E76B-4751-9C57-71FED2B39E01

Q35189691-18B9EFDC-AE8D-42CF-A780-F2D6314E5445

Q35189691-1A5D98D4-835A-4C4F-8F6B-75B8FAB07605

Q35189691-248BBA9E-8890-4539-9088-8152BA455317

Q35189691-41F7A651-5CEE-471A-8B1F-ED3BE84B7848

Q35189691-449CE04C-039B-4DC5-84FB-8A11D1D59DA0

Q35189691-47D3F9A7-B791-4611-81A3-64C3605D0764

Q35189691-4B461680-64A0-4832-AFB4-7F028F99B833

P2860

Q35189691-0E0188F8-ED80-4768-AB59-C4C000B8C3E9

Q35189691-1A4B7605-ADD3-4330-8194-EF23447107F5

Q35189691-1BDC63DC-CBCE-409A-A509-B2A377A4A829

Q35189691-21F9CC1E-D562-4DEB-8C06-02CF3EC8D815

Q35189691-32D80EC0-A394-42A7-B795-D3AF5F9052C9

Q35189691-3E886322-F849-4B29-BEDE-AC2DC78276C5

Q35189691-3FC7535E-7A27-41F4-8132-87366CCBA45E

Q35189691-4F45E5CE-3CD1-414F-9BD6-FFC48D5E5C3A

Q35189691-5F273FD0-E24D-41D9-B337-CB7F5D4D38DA

Q35189691-69F11F79-2395-4B94-BA20-7602A4E57BE6

P304

Q35189691-CF0552BE-3310-4D51-B441-2EF1E01CE50E

P31

Q35189691-BCA3EBD2-F364-4B66-AF43-5E566BCBA16F

P356

Q35189691-686AFC4A-BD72-4872-AEC6-B30B65528632

P433

Q35189691-D8A46B3F-5EF7-438E-8DE8-B0406A632D5B

P478

Q35189691-4BA09EBC-6DBC-40BE-87FC-73AACAACFD3F

P50

Q35189691-274F500B-E688-4E97-94BA-9BF7754D8A06

Q35189691-54302888-A6C6-4B0C-A6B5-C4D08293324C

Q35189691-FCBA04A1-86D7-4CD7-BEC8-06AE0A191D69

P577

Q35189691-6E5C8C85-3FCC-4EE0-BE41-67AE2412FC0E

P5875

Q35189691-A79FCD27-7E12-4EBB-848C-3E878B276EDC

P698

Q35189691-10FE98CA-9FFB-428B-9DAE-76A497522620

P921

Q35189691-B9A94EBD-BD19-49B4-9474-D850A03F8BE3

P932

Q35189691-7CD1CBCF-8878-4CC1-AD0E-CAB6365AD72D

P356

J.JAAC.2011.06.010

P1433

Journal of the American Academy of Child and Adolescent Psychiatry

P1476

Randomized controlled trial of ...... er and substance use disorders

@en

P2093

Beverly W Holmes

http://www.w3.org/2001/XMLSchema#string

Candace Hodgkins

http://www.w3.org/2001/XMLSchema#string

Charlotte Royer-Malvestuto

http://www.w3.org/2001/XMLSchema#string

Constance Klein

http://www.w3.org/2001/XMLSchema#string

David Liu

http://www.w3.org/2001/XMLSchema#string

Edward V Nunes

http://www.w3.org/2001/XMLSchema#string

Elizabeth Whitmore

http://www.w3.org/2001/XMLSchema#string

Geetha Subramaniam

http://www.w3.org/2001/XMLSchema#string

Genie L Bailey

http://www.w3.org/2001/XMLSchema#string

George E Woody

http://www.w3.org/2001/XMLSchema#string

P2860

Randomized, controlled trial of atomoxetine for attention-deficit/hyperactivity disorder in adolescents with substance use disorder.

Multisite effectiveness trials of treatments for substance abuse and co-occurring problems: have we chosen the best designs?

Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo.

Dual diagnosis and successful participation of adolescents in substance abuse treatment.

Cognitive behavioral therapy vs relaxation with educational support for medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial.

Misuse of "study drugs:" prevalence, consequences, and implications for policy.

On the learning curve: the emerging evidence supporting cognitive-behavioral therapies for adolescent substance abuse.

Efficacy of meta-cognitive therapy for adult ADHD.

Evidence-based psychosocial treatments for adolescent substance abuse.

OROS methylphenidate hydrochloride for adult patients with attention deficit/hyperactivity disorder.

P304

903-914

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JAAC.2011.06.010

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P50

Theresa Winhusen

Michelle C Acosta

P577

2011-08-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51599425

http://www.w3.org/2001/XMLSchema#string

P698

21871372

http://www.w3.org/2001/XMLSchema#string

P921

P932

3164797

http://www.w3.org/2001/XMLSchema#string